| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |